NCT00315367View on ClinicalTrials.gov

A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory Difficulties

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

October 31, 2007

Conditions
Relapsing-Remitting Multiple Sclerosis
Interventions
DRUG

Donepezil HCI (drug)

Trial Locations (1)

53226

Medical College of Wisconsin, Milwaukee

Sponsors

Lead Sponsor

Neurognostics
All Listed Sponsors
lead

Neurognostics

INDUSTRY

NCT00315367 - A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory Difficulties | Biotech Hunter | Biotech Hunter